rts logo

Genpact Ltd (G) Stock Could Soon Reward Patient Investors

Genpact Ltd (NYSE: G) is 13.20% higher on its value in year-to-date trading and has touched a low of $29.41 and a high of $39.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The G stock was last observed hovering at around $38.50 in the last trading session, with the day’s gains setting it 0.79%.

Currently trading at $39.29, the stock is 1.23% and 10.09% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing 2.05% at the moment leaves the stock 15.11% off its SMA200. G registered 7.58% gain for a year compared to 6-month gain of 17.67%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 4.58% loss in the last 1 month and extending the period to 3 months gives it a 25.01%, and is 2.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.94% over the week and 1.73% over the month.

Genpact Ltd (G) has around 129100 employees, a market worth around $7.00B and $4.59B in sales. Current P/E ratio is 11.08 and Fwd P/E is 11.61. Profit margin for the company is 14.12%. Distance from 52-week low is 33.59% and -1.65% from its 52-week high. The company has generated returns on investments over the last 12 months (17.37%).

The EPS is expected to grow by 5.95% this year.

Genpact Ltd (G) Top Institutional Holders

505.0 institutions hold shares in Genpact Ltd (G), with institutional investors hold 102.33% of the company’s shares. The shares outstanding are 179.49M, and float is at 163.28M with Short Float at 2.69%. Institutions hold 101.25% of the Float.

The top institutional shareholder in the company is FMR LLC with over 27.0 million shares valued at $868.98 million. The investor’s holdings represent 14.9628% of the G Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 19.93 million shares valued at $641.45 million to account for 11.0451 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 17.19 million shares representing 9.528% and valued at over $553.35 million, while NALANDA INDIA EQUITY FUND LTD holds 7.032 of the shares totaling 12.69 million with a market value of $408.39 million.

Genpact Ltd (G) Insider Activity

The most recent transaction is an insider sale by Kalra Balkrishan, the company’s President and CEO. SEC filings show that Kalra Balkrishan sold 7,000 shares of the company’s common stock on Sep 12 ’24 at a price of $38.54 per share for a total of $0.27 million. Following the sale, the insider now owns 0.28 million shares.

Still, SEC filings show that on Aug 14 ’24, Klunk Donald J (Chief Accounting Officer) disposed off 800 shares at an average price of $37.50 for $30003.0. The insider now directly holds 9,975 shares of Genpact Ltd (G).

Related Posts